VOLUNTARY ANNOUNCEMENT-NMPA APPROVAL OF IND APPLICATION FOR A PHASE III CLINICAL TRIAL OF SELINEXOR IN ADVANCED OR RECURRENT ENDOMETRIAL CANCER

May 12, 2021View PDF